rs4646305

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003060.4(SLC22A5):​c.498-1300G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0802 in 152,132 control chromosomes in the GnomAD database, including 611 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.080 ( 611 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

SLC22A5
NM_003060.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0820

Publications

6 publications found
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
  • systemic primary carnitine deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet, G2P, ClinGen
  • short QT syndrome
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.263 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003060.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
NM_003060.4
MANE Select
c.498-1300G>A
intron
N/ANP_003051.1O76082-1
SLC22A5
NM_001308122.2
c.570-1300G>A
intron
N/ANP_001295051.1O76082-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
ENST00000245407.8
TSL:1 MANE Select
c.498-1300G>A
intron
N/AENSP00000245407.3O76082-1
SLC22A5
ENST00000435065.7
TSL:1
c.570-1300G>A
intron
N/AENSP00000402760.2O76082-3
SLC22A5
ENST00000448810.6
TSL:1
n.498-1300G>A
intron
N/AENSP00000401860.2H7C1R8

Frequencies

GnomAD3 genomes
AF:
0.0802
AC:
12193
AN:
152014
Hom.:
614
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0727
Gnomad AMI
AF:
0.109
Gnomad AMR
AF:
0.0511
Gnomad ASJ
AF:
0.113
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.0724
Gnomad FIN
AF:
0.0772
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0755
Gnomad OTH
AF:
0.0791
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.0802
AC:
12197
AN:
152132
Hom.:
611
Cov.:
32
AF XY:
0.0797
AC XY:
5927
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0727
AC:
3018
AN:
41496
American (AMR)
AF:
0.0510
AC:
779
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
391
AN:
3472
East Asian (EAS)
AF:
0.275
AC:
1424
AN:
5172
South Asian (SAS)
AF:
0.0722
AC:
348
AN:
4818
European-Finnish (FIN)
AF:
0.0772
AC:
817
AN:
10580
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0755
AC:
5135
AN:
68002
Other (OTH)
AF:
0.0792
AC:
167
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
568
1136
1705
2273
2841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0757
Hom.:
604
Bravo
AF:
0.0782
Asia WGS
AF:
0.134
AC:
466
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.8
DANN
Benign
0.27
PhyloP100
0.082
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4646305; hg19: chr5-131718539; API